Clinical Trial: Evaluation of the Quality of Life and Gynecological Follow-up of Patients Treated for Mayer-Rokitansky-Kuster-Hauser (MRKH) Syndrome

U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07186764) titled 'Evaluation of the Quality of Life and Gynecological Follow-up of Patients Treated for Mayer-Rokitansky-Kuster-Hauser (MRKH) Syndrome' on Sept. 03.

Brief Summary: Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome affects 1 in 4,500 women and consists of utero-vaginal aplasia in 46 chromosom XX women, most often diagnosed in the presence of primary amenorrhea. This diagnosis, occurring in adolescence during the period of identity formation, can have significant psychological repercussions. This malformation can alter the body image and personal relationships of affected patients, beyond the impact on their sexual lives. Management aroun...